Patents by Inventor Mark Leslie White

Mark Leslie White has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220227857
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: January 13, 2022
    Publication date: July 21, 2022
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Patent number: 11261247
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: March 1, 2022
    Assignee: XOMA (US) LLC
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Publication number: 20180371081
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: March 14, 2018
    Publication date: December 27, 2018
    Inventors: John A. Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Publication number: 20180231545
    Abstract: The present invention provides polypeptide binding agents, e.g. antibodies, that exhibit the ability to kinetically modulate the binding and signaling of biological signaling complexes, e.g., receptor-ligand complexes; methods of identifying such polypeptide binding agents, methods of making such polypeptide binding agents, compositions comprising such polypeptide binding agents, and methods of using such polypeptide binding agents.
    Type: Application
    Filed: February 1, 2018
    Publication date: August 16, 2018
    Inventors: Mark Leslie White, Marina Roell, John A. Corbin, Robert J. Bauer, Daniel Bedinger
  • Patent number: 9944698
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 17, 2018
    Assignee: XOMA (US) LLC
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Patent number: 9725510
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: August 8, 2017
    Assignee: XOMA (US) LLC
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Publication number: 20160009800
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: November 26, 2014
    Publication date: January 14, 2016
    Inventors: JOHN CORBIN, MARK LESLIE WHITE, SUSAN R. WATSON, VINAY BHASKAR
  • Publication number: 20150322157
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: November 26, 2014
    Publication date: November 12, 2015
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Patent number: 8926976
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: September 24, 2010
    Date of Patent: January 6, 2015
    Assignee: Xoma Technology Ltd.
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Patent number: 7081334
    Abstract: The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: July 25, 2006
    Assignee: Xoma Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
  • Patent number: 6759203
    Abstract: The present invention provides a method for quantifying the presence of extracellular BPI in body fluids including blood in a subject comprising conducting a BPI immunoassay on body fluid sample obtained from said subject.
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: July 6, 2004
    Assignee: XOMA Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
  • Publication number: 20020127622
    Abstract: The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
    Type: Application
    Filed: November 26, 2001
    Publication date: September 12, 2002
    Applicant: XOMA Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-Kuen Ma
  • Patent number: 6274328
    Abstract: The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
    Type: Grant
    Filed: September 3, 1998
    Date of Patent: August 14, 2001
    Assignee: Xoma Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
  • Patent number: 5891618
    Abstract: The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: April 6, 1999
    Assignee: XOMA Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
  • Patent number: 5821064
    Abstract: The present invention provides a method for quantifying the presence of extracellular BPI in body fluids including blood in a subject comprising conducting a BPI immunoassay on body fluid sample obtained from said subject.
    Type: Grant
    Filed: September 22, 1994
    Date of Patent: October 13, 1998
    Assignee: XOMA Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
  • Patent number: 5804367
    Abstract: The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: September 8, 1998
    Assignee: Xoma Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma